Galapagos is proud to be a sponsor of United European Gastroenterology (UEG) Week 2022, one of the biggest events in the gastroenterology calendar!
Don’t miss out — join us as we travel ‘JAK to the future’ in our discussion-focussed symposium, where we will be exploring how a new era of opportunities for treatment choice might change the future for your patients with ulcerative colitis (UC).
We look forward to seeing you, both in person in Vienna and virtually, for a hybrid UEG Week 2022!
Make sure to join our internationally renowned panel as they discuss these topics, share their experiences from the clinic and answer your questions.
We look forward to welcoming you at 12:30 CEST in meeting room Strauss 2 and online!
This symposium has been funded and organised by Galapagos.
This symposium is intended for an international audience, and is not affiliated with UEG.
Professor Ailsa Hart (Chair)
St Mark’s Hospital and St Mark’s Academic Institute, London, UK
Ailsa Hart, MD, PhD, is a consultant gastroenterologist at St Mark’s Hospital and Sub-Dean of St Mark’s Academic Institute. After studying medicine at the University of Oxford, Prof. Hart gained her PhD from Imperial College London, funded by a Wellcome Trust fellowship. She has published widely in clinical, translational and basic science aspects of IBD research, and is a member of the Governing Board of the European Crohn’s and Colitis Organisation, the IBD Clinical Research Group for the British Society of Gastroenterology, and the International Organization for the Study of IBD.
Professor Raja Atreya
University Hospital Erlangen, Erlangen, Germany
Raja Atreya, MD, is Professor of Translational Immunology in IBD at the University of Erlangen–Nuremberg, as well as Head of the IBD Unit, Outpatient Clinic and Clinical Study Centre at University Hospital Erlangen. His work focusses on identifying response predictors and resistance mechanisms to biological therapies in IBD. His career has been well decorated — he received the Theodor Frerichs Award from the German Society of Internal Medicine, the Paul Ehrlich and Ludwig Darmstaedter Prize for Young Researchers from the Paul Ehrlich Foundation and the Rising Star Award from UEG.
Professor Alessandro Armuzzi
IBD Center, Humanitas Research Hospital, Humanitas University, Milan, Italy
Alessandro Armuzzi, MD, PhD, leads the IBD Center at the Humanitas Research Hospital in Milan, Italy. He gained his MD from the University of Bologna, Italy, and completed his internal medicine and gastroenterology training at the Catholic University of the Sacred Heart, Rome, Italy, before training in IBD at the John Radcliffe Hospital, Oxford, UK. Prof. Armuzzi is widely published in IBD; his research includes genetics, diagnostic modalities to assess disease activity, clinical prediction and outcome, the design and conduct of multicentre real-world trials and advanced therapy.